PIK3CA and cancer: Two major regulators of mTOR function, the RAS/MAPK and PI3K/AKT signalling pathways are constitutively activated in many cancers and are suggested as key drivers of breast tumour growth, interplaying with growth factor and steroid hormone signalling [1,3].